00:01alzheimer day
00:03alzheimer day
00:03pgi ke newro center
00:05which has opened
00:07a biochemistry lab
00:09which has started
00:11doctor indoo verma
00:13biochemistry
00:14alzheimer's condition
00:16doctor indoo verma
00:19the biochemistry
00:22test
00:24alzheimer's
00:25detect
00:25karni maya usay dhune
00:27me kitna helpful
00:28see
00:31basically
00:32kya hai ki yi test joe
00:35as per joe research show karte hai
00:38they are confirmatory test
00:39and they are for accurate diagnosis
00:41pehle joe mri pet
00:44vigera si karteh te now we can do it based on the
00:47biochemistry biomarkers also
00:49so as per
00:52these
00:53the data which is available
00:55and as per national institute of
00:57aging and alzheimer
00:59association these tests can be
01:01used for the early and accurate
01:03diagnosis of alzheimer disease
01:10so
01:14the best part of these tests is they are specific for alzheimer
01:18right
01:19so as
01:21there are actually two types of tests
01:23one are done in blood
01:25and one in csf so as dr dheeraj mentioned that they take the csf from these patients
01:32where they want to do the confirmatory diagnosis
01:35so for that the confirmatory tests are done in the csf
01:39but recently there is a test in the blood also one of these tests which we are going to do
01:46in csf
01:46that has also been approved by
01:49by the
01:52NIA
01:53for the screening of
01:55alzheimer in the blood also
01:57but these are
01:58in csf these are confirmatory tests
02:00you are right absolutely
02:26but this will help
02:30in the
02:31in the
02:32kind of a diagnosis of the alzheimer patient
02:35even in the absence of
02:37pet also
02:41finding
02:43it will give the
02:46confirmatory diagnosis
02:49if there is a patient
02:51that has come to the
02:53department
02:54has opened
02:55and now
02:56there are some confusion
02:57that
02:58the test
02:59is
03:01costly
03:01and
03:02is
03:02going to
03:02in
03:09,
03:10we have
03:11a neurologist
03:13who will send the test
03:13that is
03:16totally
03:16dependent on the neurologist
03:18that
03:19the patients
03:19understand
03:20that
03:21is
03:21that
03:21there is
03:25we have
03:26calculated
03:27the cost
03:27we have
03:28calculated
03:29the cost
03:29It is good for us to do it.
03:32Besides, these tests are at double-triple cost.
03:36So, if a neurologist says to a patient,
03:39if this is not in our institute,
03:42he will have to do it in double-triple cost.
03:45So, with that, this is a great support and help for patients.
03:51Dr. Khurana said that this is not a test for everyone.
03:57This is the one who has the worst path.
04:01The condition is very worst.
04:04The treatment has already been taken.
04:06So, the patient will have an age category for this test.
04:12Dr. Khurana said that we discussed about elderly people.
04:18After 7 years.
04:21But, someone has pointed out that it will happen soon.
04:24Dr. Khurana said that it will happen soon.
04:26So, this is why, if a neurologist fails,
04:31that it will be necessary to do it.
04:35Dr. Khurana said that there is a test available in biochemistry.
04:42Dr. Khurana said that,
04:53Dr. Khurana said that there are no tests available in biochemistry.
04:59Dr. Khurana said that the patient will result in the brain,
Comments